MiRNA-29c-3p Promotes Intestinal Inflammation via Targeting Leukemia Inhibitory Factor in Ulcerative Colitis

References

• Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol. 2003;36(5Suppl):S70–S74. doi:10.1097/00004836-200305001-00012
   PubMedGoogle Scholar
• Xie C, Yan W, Quan R, et al. Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation. Cytokine. 2020;127:154963. doi:10.1016/j.cyto.2019.154963
   PubMed Web of Science ®Google Scholar
• Bamias G, Corridoni D, Pizarro TT, Cominelli F. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine. 2012;59(3):451–459. doi:10.1016/j.cyto.2012.06.014
   PubMed Web of Science ®Google Scholar
• Dubois-Camacho K, Ottum PA, Franco-Muñoz D, et al. Glucocorticosteroid therapy in inflammatory bowel diseases: from clinical practice to molecular biology. World J Gastroenterol. 2017;23(36):6628. doi:10.3748/wjg.v23.i36.6628
   PubMed Web of Science ®Google Scholar
• Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18(5):504–511. doi:10.1101/gad.1184404
   PubMed Web of Science ®Google Scholar
• Gebert LF, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21–37.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–866. doi:10.1038/nrc1997
   PubMed Web of Science ®Google Scholar
• Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease–pathogenesis, diagnostics and therapeutics. World J Gastroenterol. 2012;18(34):4629–4634. doi:10.3748/wjg.v18.i34.4629
   PubMed Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–874. doi:10.1038/nrg3074
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441–450. doi:10.1016/j.devcel.2006.09.009
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295–312. doi:10.1146/annurev-immunol-020711-075013
   PubMed Web of Science ®Google Scholar
• Tian Y, Xu J, Li Y, et al. MicroRNA-31 reduces inflammatory signaling and promotes regeneration in colon epithelium, and delivery of mimics in microspheres reduces colitis in mice. Gastroenterology. 2019;156(8):2281–2296.e2286. doi:10.1053/j.gastro.2019.02.023
   PubMed Web of Science ®Google Scholar
• He C, Shi Y, Wu R, et al. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD. Gut. 2016;65(12):1938–1950. doi:10.1136/gutjnl-2015-309389
   PubMed Web of Science ®Google Scholar
• Nicola NA, Babon JJ. Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev. 2015;26(5):533–544. doi:10.1016/j.cytogfr.2015.07.001
   PubMed Web of Science ®Google Scholar
• Guimbaud R, Abitbol V, Bertrand V, et al. Leukemia inhibitory factor involvement in human ulcerative colitis and its potential role in malignant course. Eur Cytokine Netw. 1998;9(4):607–612.
   PubMed Web of Science ®Google Scholar
• Zhang YS, Xin DE, Wang Z, et al. STAT 4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation. EMBO J. 2019;38(6):1–20. doi:10.15252/embj.201899595
   Web of Science ®Google Scholar
• Zhang S, Jin J, Tian X, Wu L. hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC. Oncotarget. 2017;8(61):104508–104524. doi:10.18632/oncotarget.22356
   PubMedGoogle Scholar
• Grossmann J, Maxson JM, Whitacre CM, et al. New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol. 1998;153(1):53–62. doi:10.1016/S0002-9440(10)65545-9
   PubMed Web of Science ®Google Scholar
• Cooper HS, Murthy S, Shah R, Sedergran D. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238.
   PubMed Web of Science ®Google Scholar
• Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018;18(12):773–789.
   PubMed Web of Science ®Google Scholar
• Bian Z, Li L, Cui J, et al. Role of miR‐150‐targeting c‐Myb in colonic epithelial disruption during dextran sulphate sodium‐induced murine experimental colitis and human ulcerative colitis. J Pathol. 2011;225(4):544–553. doi:10.1002/path.2907
   PubMed Web of Science ®Google Scholar
• Takagi T, Naito Y, Mizushima K, et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol. 2010;25:S129–S133. doi:10.1111/j.1440-1746.2009.06216.x
   PubMed Web of Science ®Google Scholar
• Wu F, Zhang S, Dassopoulos T, et al. Identification of microRNAs associated with ileal and colonic Crohn’s disease. Inflamm Bowel Dis. 2010;16(10):1729–1738. doi:10.1002/ibd.21267
   PubMed Web of Science ®Google Scholar
• Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α. J Gastroenterol. 2008;135(5):1624–1635. doi:10.1053/j.gastro.2008.07.068
   Google Scholar
• Schmitt MJ, Margue C, Behrmann I, Kreis S. MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. Curr Mol Med. 2013;13(4):572–585. doi:10.2174/1566524011313040009
   PubMed Web of Science ®Google Scholar
• Goto Y, Ivanov II. Intestinal epithelial cells as mediators of the commensal–host immune crosstalk. Immunol Cell Biol. 2013;91(3):204–214. doi:10.1038/icb.2012.80
   PubMed Web of Science ®Google Scholar
• Kayama H, Takeda K. Regulation of intestinal homeostasis by innate and adaptive immunity. Int Immunol. 2012;24(11):673–680. doi:10.1093/intimm/dxs094
   PubMed Web of Science ®Google Scholar
• Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145–151. doi:10.1016/j.cyto.2008.01.006
   PubMed Web of Science ®Google Scholar
• Nguyen HN, Noss EH, Mizoguchi F, et al. Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators. Immunity. 2017;46(2):220–232. doi:10.1016/j.immuni.2017.01.004
   PubMed Web of Science ®Google Scholar
• Knight D. Leukaemia inhibitory factor (LIF): a cytokine of emerging importance in chronic airway inflammation. Pulm Pharmacol Ther. 2001;14(3):169–176. doi:10.1006/pupt.2001.0282
   PubMed Web of Science ®Google Scholar
• Wang H, Wang J, Zhao Y, et al. LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome. Cell Death Dis. 2020;11(7):588. doi:10.1038/s41419-020-02790-6
   PubMed Web of Science ®Google Scholar